Nektar Therapeutics
NKTR
#4504
Rank
NZ$4.08 B
Marketcap
NZ$120.92
Share price
-4.99%
Change (1 day)
587.80%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): NZ-$17.49

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$17.47. In 2024 the company made an earnings per share (EPS) of NZ-$15.17 an increase over its 2023 EPS that were of NZ-$37.50.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$17.4915.29%
2024NZ-$15.17-59.54%
2023NZ-$37.50-25.89%
2022NZ-$50.60-31.12%
2021NZ-$73.4614.86%
2020NZ-$63.95-1.19%
2019NZ-$64.72-163.96%
2018NZ$101.20-725.4%
2017NZ-$16.18-42.73%
2016NZ-$28.2583.33%
2015NZ-$15.4139.53%
2014NZ-$11.04-69.29%
2013NZ-$35.96-6.67%
2012NZ-$38.53

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.96-185.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.24-112.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.79-241.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ-$3.65-79.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.09-134.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.90-168.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
NZ$0.12-100.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$1.59-109.12%๐Ÿ‡ฎ๐Ÿ‡ช Ireland